The Medical Management of AIDSMerle A. Sande, Paul Volberding W.B. Saunders, 1995 - 740 pages This text offers health care providers and clinicians information needed to effectively care for HIV infected individuals. Included is coverage of new antiretroviral drugs and tests for quantitating viral load, which have the potential to slow the progression of the HIV virus and prolong survival. |
From inside the book
Results 1-3 of 78
Page 145
... counts > 300 / mm3 and less durable benefits ( 18 months ) in patients with CD4 cell counts < 300 / mm3 before therapy . Delaying zidovudine therapy until the CD4 cell count falls below 200 / mm3 or until the development of AIDS in ...
... counts > 300 / mm3 and less durable benefits ( 18 months ) in patients with CD4 cell counts < 300 / mm3 before therapy . Delaying zidovudine therapy until the CD4 cell count falls below 200 / mm3 or until the development of AIDS in ...
Page 518
... counts before beginning therapy , so the contribution of ganciclovir to leukopenia may not be entirely clear . Nonetheless , the dosage should be reduced when absolute neutrophil counts fall below 1000 / mm3 or discontinued when severe ...
... counts before beginning therapy , so the contribution of ganciclovir to leukopenia may not be entirely clear . Nonetheless , the dosage should be reduced when absolute neutrophil counts fall below 1000 / mm3 or discontinued when severe ...
Page 615
... counts longitudinally in HIV - infected and uninfected gravidas through the postpartum period . They found that whereas both groups exhibited a decrease in the number of CD4 - bearing lymphocytes during pregnancy , the counts of the HIV ...
... counts longitudinally in HIV - infected and uninfected gravidas through the postpartum period . They found that whereas both groups exhibited a decrease in the number of CD4 - bearing lymphocytes during pregnancy , the counts of the HIV ...
Other editions - View all
Common terms and phrases
abnormalities Acquir Immune acquired immunodeficiency syndrome activity acute acyclovir advanced HIV disease adverse reactions agents AIDS dementia complex AIDS patients AIDS-related AIDS-related complex alternative therapies Ann Intern antibody antigen associated asymptomatic biopsy blood candidiasis CD4 cell counts CD4 count CD4+ chronic Clin Conference on AIDS cryptococcal culture cytomegalovirus dapsone decreased depression detected diagnosis diarrhea didanosine disease progression disorders dose drug effects Engl evaluation exposure fluconazole gene Greenspan hairy leukoplakia herpes HIV infection HIV-associated HIV-infected patients human immunodeficiency virus immunodeficiency virus infection immunodeficiency virus type increased itraconazole Kaposi's sarcoma ketoconazole Lancet lesions levels lymphocyte lymphoma meningitis Mycobacterium neurologic occur p24 antigen patients with advanced patients with AIDS pentamidine plasma Pneumocystis carinii pneumonia potential primary HIV-1 infection prophylaxis protein replication reported response result rifampin risk San Francisco serum symptoms T-cell tissue toxicity Toxoplasma toxoplasmosis treatment tuberculosis ulcers viral vitro zalcitabine zidovudine zidovudine therapy